Article Information
History
- October 26, 2020.
Article Versions
- Version 1 (October 26, 2020 - 10:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Mohau S. Makatsa*,
- F. Millicent A. Omondi*,
- Rubina Bunjun*,
- Robert J. Wilkinson†,‡,§,¶,
- Catherine Riou*,†,‡,1 and
- Wendy A. Burgers*,†,‡,1,#
- *Division of Medical Virology, Department of Pathology, Faculty of Health Sciences
- †Wellcome Centre for Infectious Diseases Research in Africa
- ‡Institute of Infectious Disease and Molecular Medicine, University of Cape Town, 7925, Cape Town, South Africa
- §Department of Medicine, Imperial College London, W21PG, London, UK
- ¶Francis Crick Institute Mill Hill laboratory, NW71AA, London, UK
- ↵#Corresponding author:
Wendy Burgers, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Falmouth Building, Room 3.36.1, Observatory 7925, South Africa. Phone: +27 21 406 6090, e-mail: wendy.burgers{at}uct.ac.za
↵1 C.R. and W.A.B. contributed equally to this work.
Posted October 26, 2020.
Characterization of Mycobacterium tuberculosis-specific Th22 cells and the effect of tuberculosis disease and HIV co-infection
